Furthermore, our results strongly suggest that CIITA-induced MHC class II cell surface molecules in GL261-CIITA tumor cells are the key element in triggering the adaptive CD4+ Th cell anti-tumor response, most likely serving as antigen-presenting molecules for tumor-specific GBM peptide antigens. This evidence concerns the gene CD4 and glioblastoma.